Cargando…
COVID-19 vaccine effectiveness studies in Nigeria: Quo vadis?
Autores principales: | Akande, Oluwatosin Wuraola, Igumbor, Ehimario Uche, Elimian, Kelly Osezele, Ohonsi, Cornelius Ehizokhai, Nwozor, Lilian, Oden, Okanke, Ekpenyong, Emmanuel Nsa, Ndodo, Nnaemeka, Ike, Ifeanyi F, Egede, Magdalene, Nwachukwu, William, Onoja, Amedu M, Fofah, Jenson Gawain, Azi, Reuben Ishiaku, Ochu, Chinwe L, Adetifa, Ifedayo M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Society of Global Health
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9344979/ https://www.ncbi.nlm.nih.gov/pubmed/35916589 http://dx.doi.org/10.7189/jogh.12.03055 |
Ejemplares similares
-
Epidemiological trends of Lassa fever in Nigeria, 2018–2021
por: Dalhat, Mahmood M., et al.
Publicado: (2022) -
Predictors of Lassa fever diagnosis in suspected cases reporting to health facilities in Nigeria
por: Ochu, Chinwe Lucia, et al.
Publicado: (2023) -
Public risk perception and behaviours towards COVID-19 during the first and second waves in Nigeria: a secondary data analysis
por: Ochu, Chinwe Lucia, et al.
Publicado: (2022) -
Places Nigerians visited during COVID-19 government stay-home policy: evidence from secondary analysis of data collected during the lockdown
por: Olatunji, David Idowu, et al.
Publicado: (2023) -
Assessing the capacity of symptom scores to predict COVID-19 positivity in Nigeria: a national derivation and validation cohort study
por: Elimian, Kelly Osezele, et al.
Publicado: (2021)